Integrated Pharmaceutical Solutions From Discovery to Commercialization
PRECISION PHARMA SOLUTIONS • 25 YEARS OF EXCELLENCE • GLOBAL REACH • USFDA INSPECTED FACILITIES • CDMO LEADERSHIP
Active Pharmaceutical Ingredients (APIs)
Contract Research Organization (CRO)
Contract Development & Manufacturing Organization (CDMO)
Comprehensive contract research services focused on analytical validation and impurity profiling excellence.
Comprehensive contract research services focused on analytical validation and impurity profiling excellence.
Seamless scale-up from pilot clinical batches to large-scale commercial pharmaceutical supply.
At Cytonova, we provide comprehensive pharmaceutical services spanning API Development & Manufacturing, Contract Research Organization (CRO) Services, and Contract Development & Manufacturing Organization (CDMO) Solutions. Our integrated capabilities enable pharmaceutical, biotechnology, and healthcare companies to accelerate innovation, reduce development timelines, and bring quality therapies to global markets.
Quality & Compliance
Adhering to global GxP standards with USFDA-inspected facilities and rigorous regulatory oversight.
Specialized Capabilities
Advanced aseptic processing, lyophilization, and robotic sterile finishing for parenterals.
Supply Chain
Agile global logistics network ensuring seamless pharmaceutical delivery across 50+ countries.
Global Operational Excellence & Impressive Scale
25+
Years' Experience
20
NCEs Commercialized
2500+
Scientists
35
USFDA cGMP Facilities
125+
Global Clients
6
Biologics Commercialized
600+
Discovery & CDMO Projects
50
Manufacturing Countries
Cytonova Labs: Global Operational Excellence & World-Class Scale
Driving Innovation Through Global Standards, Scientific Excellence, and Scalable Operations
At Cytonova Labs, we combine scientific expertise, advanced technology, and globally aligned operational systems to deliver pharmaceutical solutions that meet the highest international standards. As a trusted partner for API Development, CRO Services, and CDMO Manufacturing, we provide end-to-end support that enables pharmaceutical and biotechnology companies to accelerate development, optimize manufacturing, and successfully commercialize products across global markets.
Our commitment to operational excellence is embedded in every aspect of our business, from research and process development to quality assurance, regulatory compliance, technology transfer, and commercial production. Through a culture of continuous improvement, innovation, and customer-centric execution, we consistently deliver reliable, scalable, and compliant solutions that drive long-term success for our partners worldwide.
Cytonova Labs serves clients across North America, Europe, Asia-Pacific, the Middle East, Latin America, and emerging healthcare markets. Our globally focused business model enables us to support multinational pharmaceutical companies, specialty pharma organizations, biotech innovators, and research-driven enterprises with customized solutions tailored to regional regulatory and market requirements.
Our Global Capabilities Include:
-
International quality systems aligned with global regulatory expectations
-
Seamless project execution across multiple geographies
-
Strong regulatory support for global market submissions
-
Strategic partnerships with international pharmaceutical innovators
-
Flexible supply chain and manufacturing solutions
-
Scalable development programs from discovery through commercialization
Manufacturing Excellence
Our manufacturing operations are designed for efficiency, flexibility, and scalability, supporting projects from laboratory-scale synthesis to full commercial production.
Continuous Improvement Culture
Through Lean principles, process optimization, digital systems, and operational best practices, we continuously enhance productivity, quality performance, and customer satisfaction.
📈 Impressive Scale & Technical Strength
World-Class Infrastructure
-
Advanced R&D Laboratories
-
Pilot Scale Development Facilities
-
Commercial Manufacturing Capabilities
-
Dedicated Analytical Development Centers
-
Robust Quality Control & Quality Assurance Laboratories
-
Modern Technology Transfer and Process Engineering Platforms
Scientific and Technical Expertise
-
Highly experienced scientists, engineers, and pharmaceutical specialists
-
Cross-functional expertise spanning chemistry, process engineering, analytics, quality, and regulatory affairs
-
Proven success in complex molecule development and scale-up projects
-
Extensive experience supporting global pharmaceutical programs
Scalable Development & Manufacturing
-
Milligram to kilogram development capabilities
-
Pilot plant scale-up expertise
-
Commercial manufacturing readiness
-
Flexible batch sizes based on customer requirements
-
Reliable technology transfer and process validation support
Our Vision
Advancing global access to safe, high-quality therapies through pioneering pharmaceutical innovation and accessible healthcare solutions.
Our Mission
Driving end-to-end pharmaceutical excellence from R&D to commercial supply with unmatched manufacturing standards and regulatory compliance.
Core Values
Quality, compliance, and relentless innovation focused on patient-centricity to improve health outcomes globally.
GLOBAL CDMO LEADERSHIP • USFDA APPROVED FACILITIES • PURE API INNOVATION • STRATEGIC CLINICAL PARTNERS •
Advanced Pharma Solutions Portfolio
Accelerate your therapeutic pipeline with a partner engineered for high-complexity API synthesis and CDMO excellence. Cytonova Labs integrates QbD-driven process development with global GxP regulatory standards to de-risk scale-up and compress commercial timelines.
High-Purity API Synthesis
Proprietary synthesis protocols ensuring 99.8%+ purity levels. Engineered for complex small molecule programs requiring rigorous crystalline structure validation.
CDMO Commercial Scale-up
Seamless transition from pilot batches to cGMP commercial supply. Optimized PAT strategies reduce time-to-market while maintaining full regulatory compliance.
CRO Analytical Validation
Advanced impurity profiling and GxP-compliant method development. Our analytical suite reduces discovery lead times by 25% for critical therapeutic candidates.
Sterile API Finishing
High-efficiency aseptic processing and lyophilization services. Our robotic automation ensures 100% sterile integrity for complex parenteral formulations.
Why Partner with Cytonova?
Scientific Expertise
Experienced team of chemists and pharmaceutical professionals.
Integrated Model
Single-source partner for API synthesis and CDMO needs.
Quality Standards
Processes aligned with global regulatory expectations.
Scalability
From discovery quantities to commercial production.
Reliable Partnership
Long-term collaboration for supply continuity.